Taiwan Shares Surge 1.30 Percent -- Feb. 16
Posted on: Friday, 17 February 2006, 09:00 CST
Taiwan shares surge 1.30 percent -- Feb. 16
HONG KONG, Feb. 16 (Xinhua) -- Taiwan share prices rose 1.30 percent with a slightly thinner traded volume on Thursday, according to reports reaching here from Taipei.
The weighted index, key barometer of the Taiwan Stock Exchange, went up 85.44 points to close at 6,683.93.
The bourse opened at 6,661.30 and fluctuated between 6,701.74 and 6,647.03 during trading.
A total of 3.41 billion shares were transacted on a market turnover of 104.22 billion HK dollars (3.22 billion US dollars), down from Wednesday's turnover of turnover of 104.65 billion new Taiwan dollars (3.23 billion U.S. dollars).
All eight major stock categories gained ground, with machinery and electronics shares moving up the most at 2 percent, followed by paper and pulp issues at 0.9 percent, cement stocks and foodstuff issues both at 0.8 percent, textile stocks at 0.5 percent, banking and financial shares at 0.4 percent, construction issues at 0.2 percent, and plastics and chemicals shares at 0.02 percent.
Gainers outnumbered losers 686 to 286, with 207 stocks remaining unchanged.
Source: Xinhua News Agency - CEIS
Related Articles
- truth(R) Campaign Can Save Half a Million Lives and Billions of Dollars
- Syndication Inc. Board of Directors Authorizes the CEO to Rescind 300 Million Shares of the Company's Common Stock to Treasury
- A Drug That Improves Exercise Capacity By a Greater Percentage Than Tracleer Would Earn a 48 Percent Patient Share in the Pulmonary Arterial Hypertension Market
- A Weight Neutral Oral Antidiabetic Drug Would Earn a 25 Percent Patient Share in the Type 2 Diabetes Drug Market
- A Drug With Efficacy Superior to That of Remicade at Inducing Closure and Healing of Fistulas Would Earn a 30 Percent Patient Share in the Crohn's Disease Drug Market
- AstraZeneca's Recentin Plus FOLFOX4 to Earn 10 Percent Patient Share in the Treatment of Colorectal Cancer By 2016
- AstraZeneca's Zactima to Earn Almost Five Percent Patient Share in the Treatment of Non-Small-Cell Lung Cancer By 2016
- 1 Billion Shares Locked Up
- Zambia Foresees 2 Billion US Dollars FDI in 2005
- The Immune Response Corporation Issues Common Stock to Major Investor in Exchange for All Preferred Stock
 |
 |
User Comments (0)
RSS Feeds